OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
876956

Advantage Risk Management Co Ltd

Healthcare Facilities & ServicesVerified

The company maintains a strong liquidity position, with a current ratio of 1.29 and cash and equivalents amounting to 1,428,867,000 JPY. This liquidity is supported by a low debt-to-equity ratio of 0.09, indicating a conservative capital structure. Profitability metrics show a return on equity of 7.79% and a return on assets of 4.74%, which are in line with the industry's preferred metrics. The operating income of 442,585,000 JPY and net income of 310,234,000 JPY reflect a healthy margin, suggesting efficient operations. The company's revenue is primarily concentrated in its core healthcare services and equipment segment, with no significant geographic diversification disclosed. This concentration may pose a risk if the core market experiences downturns. Looking ahead, the company is projected to maintain its growth trajectory, with a positive outlook for the current and next fiscal years. The operating cash flow of 1,292,086,000 JPY supports this growth, although capital expenditures of -876,246,000 JPY indicate ongoing investment in infrastructure. Risk factors are minimal, with low liquidity and dilution risks identified. There are no immediate filing-based liquidity or dilution flags, and the dilution potential is low. The company's conservative capital structure and strong cash reserves further mitigate these risks. Recent events, including the latest financial filings and transcripts, do not indicate any significant changes in the company's strategic direction or operational performance. The company continues to focus on its core healthcare services and equipment segment.

30-day price · 8769+21.00 (+4.6%)
Low$451.00High$503.00Close$478.00As of16 May, 00:00 UTC
Profile
CompanyAdvantage Risk Management Co Ltd
Ticker8769.T
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Advantage Risk Management Co Ltd provides healthcare services and equipment, primarily generating revenue through service provision and product sales.

Classification. The company is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a high confidence level of 0.92.

The company maintains a strong liquidity position, with a current ratio of 1.29 and cash and equivalents amounting to 1,428,867,000 JPY. This liquidity is supported by a low debt-to-equity ratio of 0.09, indicating a conservative capital structure. Profitability metrics show a return on equity of 7.79% and a return on assets of 4.74%, which are in line with the industry's preferred metrics. The operating income of 442,585,000 JPY and net income of 310,234,000 JPY reflect a healthy margin, suggesting efficient operations. The company's revenue is primarily concentrated in its core healthcare services and equipment segment, with no significant geographic diversification disclosed. This concentration may pose a risk if the core market experiences downturns. Looking ahead, the company is projected to maintain its growth trajectory, with a positive outlook for the current and next fiscal years. The operating cash flow of 1,292,086,000 JPY supports this growth, although capital expenditures of -876,246,000 JPY indicate ongoing investment in infrastructure. Risk factors are minimal, with low liquidity and dilution risks identified. There are no immediate filing-based liquidity or dilution flags, and the dilution potential is low. The company's conservative capital structure and strong cash reserves further mitigate these risks. Recent events, including the latest financial filings and transcripts, do not indicate any significant changes in the company's strategic direction or operational performance. The company continues to focus on its core healthcare services and equipment segment.
Key takeaways
  • Advantage Risk Management Co Ltd has a strong liquidity position with a current ratio of 1.29 and significant cash reserves.
  • The company's profitability metrics, including a return on equity of 7.79%, are in line with industry standards.
  • Revenue is primarily concentrated in the healthcare services and equipment segment, with no significant geographic diversification.
  • The company is projected to maintain its growth trajectory, supported by a positive operating cash flow.
  • Risk factors are minimal, with low liquidity and dilution risks identified.
  • # RATIONALES
  • **margin_outlook_rationale**: The company's operating margin is expected to remain stable due to efficient cost management and strong demand for healthcare services.
  • **rd_outlook_rationale**: Research and development expenditures are not disclosed, but the company's focus on healthcare services suggests ongoing innovation.
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$2.00B
Gross profit$1.48B
Operating income$442.6M
Net income$310.2M
R&D
SG&A
D&A
SBC
Operating cash flow$1.29B
CapEx-$876.2M
Free cash flow
Total assets$6.55B
Total liabilities$2.56B
Total equity$3.98B
Cash & equivalents$1.43B
Long-term debt$344.7M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$5.45B$737.9M$496.2M-$206.0M
FY-3$5.79B$329.5M$201.8M-$532.0M
FY-2$6.41B$549.4M$377.6M-$116.4M
FY-1$7.00B$725.8M$505.6M$130.6M
FY0$8.55B$788.1M$744.4M$642.0M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$5.87B$3.69B$2.76B
FY-3$5.68B$3.43B$717.9M
FY-2$5.96B$3.64B$1.27B
FY-1$6.55B$3.98B$1.43B
FY0$8.72B$3.96B$1.73B
PeriodOCFCapExFCFSBC
FY-4$712.6M-$783.0M-$206.0M
FY-3$579.0M-$962.0M-$532.0M
FY-2$931.6M-$853.7M-$116.4M
FY-1$1.29B-$876.2M$130.6M
FY0$1.71B-$733.5M$642.0M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$2.00B$442.6M$310.2M
FQ-6$1.64B$52.9M$37.0M
FQ-5$1.72B-$129.1M-$162.5M
FQ-4$2.56B$448.0M$303.9M
FQ-3$2.63B$416.3M$566.0M
FQ-2$2.24B$145.0M$97.2M
FQ-1$2.32B$135.4M$89.5M
FQ0$2.66B$351.3M$246.0M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$6.55B$3.98B$1.43B
FQ-6$6.65B$3.73B$1.90B
FQ-5$8.49B$3.35B$1.93B
FQ-4$8.17B$3.39B$1.55B
FQ-3$8.72B$3.96B$1.73B
FQ-2$9.00B$3.98B$2.01B
FQ-1$9.25B$4.10B$2.13B
FQ0$8.62B$4.17B$2.00B
PeriodOCFCapExFCFSBC
FQ-7$1.29B-$876.2M
FQ-6
FQ-5$1.14B-$342.7M
FQ-4
FQ-3$1.71B-$733.5M
FQ-2
FQ-1$1.51B-$402.8M
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$3.98B
Net cash$1.08B
Current ratio1.3
Debt/Equity0.1
ROA4.7%
ROE7.8%
Cash conversion4.2%
CapEx/Revenue-43.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Biotechnology · cohort 117 companies
Metric8769Activity
Op margin22.1%5.6% medp25 -4.2% · p75 12.6%top quartile
Net margin15.5%2.8% medp25 -3.4% · p75 8.8%top quartile
Gross margin74.3%36.5% medp25 23.7% · p75 65.2%top quartile
CapEx / revenue-43.9%-4.9% medp25 -11.5% · p75 -2.0%bottom quartile
Debt / equity9.0%69.3% medp25 7.9% · p75 120.9%below median
Observations
IR observations
Last actual EPS46.13 JPY
Last actual revenue8,554,080,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-13 00:05 UTC#4fb6cadd
Market quoteclose JPY 481.00 · shares 0.02B diluted
no public URL
2026-05-13 00:05 UTC#7babdcec
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 04:32 UTCJob: ae02ed5d